SINOVAC: Supply Vaccines to Eliminate Human Diseases

News & Events

2024/06/18

SINOVAC's Varicella Vaccine was Approved by China National Medical Products Administration (NMPA) for Use in Adolescents and Adults Aged 13 Years Old and Above

Beijing, China – June 18, 2024 – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its PROV

SINOVAC Made Major Announcements Today

On June 4, 2024, Vice-President of Brazil and Minister for Development, Industry and Trade Geraldo Alckmin met with Mr. Yin Weidong, Chairman, President, and CEO of SINOVAC, in Beijing, China. Vice-Pr

2024/06/05
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and E

2024/04/30
China National Medical Products Administration Granted Approval to SINOVAC's 5-dose Inactivated Poliomyelitis Vaccine

Beijing, China – April 12, 2024 – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its Pol

2024/04/12

R&D and Innovation

SINOVAC has undertaken nearly 60 national and regional science and technology
R&D projects; received two State Scientific and Technology Progress Awards
and three national-level institutional technology awards; and published more than
140 SCI papers, many of which were published in top academic journals including
New England Journal of Medicine, The Lancet, Science and Nature, etc.

Our Vaccines

SINOVAC approved products include: COVID-19 Vaccine (Vero Cell), Inactivated - CoronaVac®, Enterovirus Type 71 Vaccine (Vero cell), Inactivated - Inlive®, Hepatitis A Vaccine (Human Diploid Cell) Inactivated - Healive®, Influenza Vaccine (Split Virion), Inactivated - Anflu®, 23-valent Pneumococcal Polysaccharide Vaccine, Varicella Vaccine(Live), Mumps Vaccine(Live), etc.

COVID-19 Vaccine (Vero Cell), Inactivated - CoronaVac^®

Validated by the World Health Organization's Emergency Use Listing ("EUL") Procedure on June 2, 2021

Enterovirus Type 71 Vaccine (Vero cell), Inactivated - Inlive^®

Validated by the World Health Organization's Emergency Use Listing ("EUL") Procedure on June 2, 2021

Hepatitis A Vaccine (Human Diploid Cell), Inactivated - Healive^®

Launched in 2002.

Influenza Vaccine Product Family

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent. Influenza Vaccine (Split Virion), Inactivated - Anflu^®. Pandemic Influenza Vaccine (Inactivated, Adjuvanted) - Panflu^®. H1N1 Influenza A Vaccine (Split Virion), Inactivated - Panflu.1^®.